Importance of baseline cotinine plasma values in smoking cessation: Results from a double-blind study with nicotine patch

European Respiratory Journal

Volumn 9, Issue 4, 1996, Pages 643-651

  Paoletti, P ^a,c,d   Fornai, E ^a   Maggiorelli, F ^a   Puntoni, R ^a   Viegi, G ^a   Carrozzi, L ^a   Corlando, A ^a   Gustavsson, G ^b   Sawe U ^b   Giuntini, C ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Pharmacia and Upjohn   (Sweden)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^d Eti Lilly Italy Medical Division   (Italy)

Author keywords

Plasma cotinine; prediction of outcome; smoking cessation; transdermal nicotine replacement

Indexed keywords

NICOTINE; NICOTINE GUM;

ABSTINENCE; ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG WITHDRAWAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TRANSDERMAL DRUG ADMINISTRATION;

ADULT; COTININE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 9344246839     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09040643     Document Type: Article

References (30)

1. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992; 339: 1268-1278.
2. Prignot J. Pharmacological approach to smoking cessation. Eur Respir J 1989; 2: 550-560.
3. US Department of Health and Human Services. Nicotine addiction. A report of the Surgeon General, USA, 1988.
4. Abelin T, Buehler A, Muller B, Vesanen K, Imhof PR. Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet 1989; 1: 7-10.
5. Tønnesen P, Fryd V, Hansen M, et al. Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking. N Engl J Med 1988; 318: 15-18.
6. Tønnesen P, Norregaard J, Simonsen K, et al. A double-blind trial of a 16 hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991; 325: 311-315.
7. Hurt RD, Lauger GG, Offord KP, Kottke TE, Dale LC. Nicotine-replacement therapy with use of a transdermal nicotine patch - a randomized double-blind placebo-controlled trial. Mayo Clin Proc 1990; 65: 1529-1537.
8. Sachs DPL, Säwe U, Leischow SJ. Effectiveness of a 16 hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Arch Intern Med 1993; 153: 1881-1890.
9. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. J Am Med Assoc 1991; 266: 3133-3138.
10. Russell MAH, Stapleton JA, Feyerabend C, et al. Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. Br Med J 1993; 306: 1308-1312.
11. Imperial Cancer Research Fund General Practice Research Group. Effectiveness of a nicotine patch in helping people stop smoking: results of a randomized trial in general practice. Br Med J 1993; 306: 1304-1308.
12. Daughton DM, Heatley SA, Prendergast JJ, et al. Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. Arch Intern Med 1991; 151: 749-752.
13. Sutherland G, Stapleton JA, Russell MAH, et al. Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992; 340: 324-329.
14. Tønnesen P, Norregaard J, Mikkelsen K, Jorgensen S, Nilsson F. A double-blind trial of a nicotine inhaler for smoking cessation. J Am Med Assoc 1993; 269: 1268-1271.
15. Hall SM, Herning RI, Jones RT, Benowitz NL, Jacob P III. Blood cotinine levels as indicators of smoking treatment outcome. Clin Pharmacol Ther 1984; 35: 810-814.
16. Tønnesen P, Norregaard J, Säwe U, Simonsen K. Recycling with nicotine patches in smoking cessation. Addiction 1993; 88: 533-539.
17. Sachs DPL, Benowitz NL, Bostrom AG, Hansen MD. Percent serum replacement and success of nicotine patch therapy. Am J Respir Crit Care Med 1995; 151: A688.
18. Feyerabend C, Russell MAH. A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. J Pharm Pharmacol 1990; 42: 450-452.
19. American Thoracic Society. Standardization of spirometry: 1987 update. Am Rev Respir Dis 1987; 136: 1285-1298.
20. Kellner R, Sheffield B. A self-rating scale of distress. Psychol Med 1973; 3: 88-100.
21. Eysenck HY, Eysenck SBG. In: Manual of Eysenck Personality Inventory. Sevenoaks, England, Hodder & Stoughton, 1975.
22. Fagerström KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerström Tolerance Questionnaire. J Behav Med 1989; 12: 159-182.
23. Paoletti P, Pistelli G, Fazzi P, et al. Reference values for vital capacity and flow-volume curves from a general population study. Bull Eur Physiopathol Respir 1986; 22: 451-459.
24. Hurt RD, Dale LC, Fredrickson PA, et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. J Am Med Assoc 1994; 271: 596-600.
25. Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation. Who will quit with and without nicotine patch. J Am Med Assoc 1994; 271: 589-594.
26. Stapleton JA, Russell MAH, Feyerabend C, et al. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction 1995; 90: 31-42.
27. Jarvis M, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Biochemical markers of smoke absorption and self-reported exposure to passive smoking. J Epidemiol Commun Health 1984; 38: 335-339.
28. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J 1976; 2: 1525-1536.
29. Dockery DW, Speizer FE, Ferris BG Jr, et al. Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adults. Am Rev Respir Dis 1988; 137: 286-292.
30. US Department of Health and Human Services. Health consequences of smoking: cardiovascular disease, a report of the Surgeon General. Public Health Service, Office on Smoking and Health, Rockville, Maryland 20857, 1983.